Metabolic characterization of triple negative breast cancer
2014 · BMC Cancer · 152 citations
https://doi.org/10.1186/1471-2407-14-941
A
Anna M. Bofin
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
106
Papers
2.3K
Citations
28
h-index
55
i10-index
Anna M. Bofin is an academic researcher from Norwegian University of Science and Technology. The author has contributed to research in topics: Breast Cancer Treatment Studies & Breast Lesions and Carcinomas & Computational Drug Discovery Methods. The author has an h-index of 28, co-authored 91 publications.
ORCID: 0000-0002-8111-4338Papers by this author
worksPrognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy
2012 · BMC Cancer · 115 citations
https://doi.org/10.1186/1471-2407-12-39
CCND1 Amplification in Breast Cancer -associations With Proliferation, Histopathological Grade, Molecular Subtype and Prognosis
2022 · Journal of Mammary Gland Biology and Neoplasia · 45 citations
https://doi.org/10.1007/s10911-022-09516-8
Molecular Subtypes of Breast Cancer: Long-term Incidence Trends and Prognostic Differences
2016 · Cancer Epidemiology Biomarkers & Prevention · 42 citations
https://doi.org/10.1158/1055-9965.epi-16-0427
The expression of the long NEAT1_2 isoform is associated with human epidermal growth factor receptor 2-positive breast cancers
2020 · Scientific Reports · 33 citations
https://doi.org/10.1038/s41598-020-57759-4
SFRP4 gene expression is increased in aggressive prostate cancer
2017 · Scientific Reports · 28 citations
https://doi.org/10.1038/s41598-017-14622-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat